S-Equol in Alzheimer's Disease 2 Trial

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Alzheimer Disease

In brief

By doing this study researchers hope to learn if S-equol, a compound that acts like estrogen in the body, causes an increase in mitochondrial activity. Researchers also hope to determine the safety and tolerability of a therapeutic dose of S-equol and whether or not it influences cognition.

Key facts

Study ID
NCT03101085
Run by
Russell Swerdlow
People needed
40
Starts
2017-05-05
Expected to finish
2021-03-01
Last updated by the study team
2024-07-25

Who can join

Age: 50 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.